REGISTERED
on 22 Nov 2022
Last Applicant/ Owned by
Chuo-ku, Osaka-shi
Osaka
JP
541-8505
Serial Number
90594021 filed on 22nd Mar 2021
Registration Number
6908091 registered on 22nd Nov 2022
Correspondent Address
Jeffrey Costellia
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
RADICAVA ORS
Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
First Use Date in General
15th Jun 2022
First Use Date in Commerce
15th Jun 2022
Mark Details
Serial Number
No 90594021
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 740630-234
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd Nov 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 22nd Nov 2022 | REGISTERED-PRINCIPAL REGISTER |
| 15th Oct 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 14th Oct 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 21st Sep 2022 | ASSIGNED TO EXAMINER |
| 06th Aug 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th Aug 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Jul 2022 | USE AMENDMENT FILED |
| 20th Jul 2022 | TEAS STATEMENT OF USE RECEIVED |
| 25th Jan 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |